Wednesday, July 15, 2026

Xerafy Unveils Innovative RFID Labels for Healthcare at CPHI Southeast Asia 2026

Xerafy is set to unveil its innovative RAIN RFID labeling solutions tailored for the pharmaceutical and healthcare sectors at the AIPIA Innovation Stage during CPHI South East Asia 2026. The event will occur from July 8 to 10 in Bangkok, Thailand, providing a platform for the company to highlight how its technology can enhance packaging, traceability, and inventory management in the healthcare supply chain.

Among the solutions Xerafy will present are the XSKIN Gamma, designed for gamma-sterilized packaging; the MICRO Medical, intended for compact medical device identification; and the Metal Skin Delta, suitable for on-metal healthcare assets and metallized packaging. These products are aimed at improving the accuracy and efficiency of pharmaceutical supply chains, which are becoming more complex and demanding.

The company’s smart RAIN RFID labels offer significant benefits by enabling item-level identification and real-time data capture across various stages, including manufacturing, sterilization, warehousing, distribution, and healthcare workflows. This technology is crucial for enhancing product traceability, ensuring inventory accuracy, and maintaining compliance by linking physical products with their digital records.

Xerafy emphasizes that its RFID solutions are particularly effective in challenging environments where traditional barcode systems might falter. This is especially relevant in scenarios involving bulk handling, dense storage, and regulated healthcare applications. The company’s RFID portfolio extends beyond healthcare, with applications in manufacturing, logistics, aerospace, oil and gas, data centers, and other industrial sectors.

The upcoming showcase at CPHI South East Asia 2026 aims to demonstrate how connected packaging and RFID technology can lead to more efficient pharmaceutical and medical device supply chains, underscoring Xerafy’s commitment to innovation in this field.

Legal Disclaimer: The information contained in this article has been provided by independent third-party contributors, clients, or content partners. We do not independently verify the accuracy, completeness, legality, ownership, licensing, or reliability of submitted content, including text, images, videos, trademarks, or other media materials. The submitting party is solely responsible for ensuring that all content, including images and media assets, complies with applicable copyright, trademark, licensing, and intellectual property laws. We disclaim liability for any unauthorized use of copyrighted or proprietary materials by third parties. If you believe that any content published on this platform infringes your intellectual property rights, kindly contact the author above for prompt review and resolution.

RELATED ARTICLES

Most Popular